Patient guides
What Is Stem Cell Therapy? Types, Uses & Limitations
Cell source, cell type and intended use are separate questions. This introduction puts the terminology in context.
Stem cells can renew themselves and produce specialized cells. Those biological properties help explain the research interest; they do not prove that a particular marketed injection will treat a condition.
What makes a stem cell different?
MedlinePlus describes stem cells through their capacity for self-renewal and differentiation. Different types have different capabilities. Adult tissue stem cells are not interchangeable with pluripotent cells used in research. The term “stem cell” therefore covers a family of biological materials, not one medicine. MedlinePlus introduction.
Four details identify the proposal
| Detail | What it tells you |
|---|---|
| Source | Where the material originates: for example, the patient’s fat, marrow or another specified source. |
| Processing | What happens between collection and administration, including separation, expansion or storage where relevant. |
| Route | How and where the preparation is administered. |
| Indication | The precise condition or goal for which the procedure is proposed. |
Write these details together. A study that matches only one or two may not answer the question about your proposed treatment.
Autologous and allogeneic are source terms
Autologous means the material comes from the patient. Allogeneic means it comes from a donor. Neither word alone establishes clinical benefit or safety. Source identity must be considered alongside processing, quality control, dose, route and the medical purpose.
For a donor-derived product, ask for the exact product identity and relevant documentation. For an autologous procedure, ask what happens to the collected material and how it is characterized before use.
Why research findings need context
Laboratory experiments can explore a biological mechanism. Human studies address different questions: what dose is tolerable, what adverse events occur, whether there is a benefit compared with another treatment and how long that benefit lasts. Those are steps in evaluation, not interchangeable kinds of proof.
A credible explanation should identify what is known, what remains uncertain and what is relevant to the exact proposed procedure. The evidence guide explains how to read those distinctions.
Where to go next
If you have a diagnosis, begin with the relevant patient concern guide. If you already have a clinic proposal, identify its preparation in the treatment approach overview. If you are preparing to travel, use the patient journey to check what should be arranged before and after the visit.
Sources and further reading
- MedlinePlus / NIH — Stem cellsSource checked 9 October 2026.
- ISSCR — Patient resourcesSource checked 9 October 2026.